le it appears that the <em>E. coli</em> periplasmic redox partners are present in sufficient quantity to allow the CYP to have activity, smaller amounts of reductase system may be present or inefficient coupling may be occurring. However, here we do validate this approach as a suitable one for use in order to obtain heterologous CYP105D1 at a high concentration and as an active protein in an advantageous, accessible cellular location.  <div><div class="p"><strong>TABLE 1</strong></div><div class="p"> <div c